HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis.

Abstract
We evaluated the efficacy of ciprofloxacin (3 mg/ml) as the sole topical antibiotic used to treat infectious keratitis in 14 patients. We compared the ciprofloxacin-treated group to a retrospective control group of 30 consecutive culture-positive patients treated with conventional therapy in which cefazolin (50 mg/ml) and fortified gentamicin sulfate (9.1 mg/ml) solutions were used. We found no remarkable difference between the control group and the ciprofloxacin-treated group regarding patient age, risk factors, need for hospitalization, and virulence of organism isolated. The average time to healing in culture-positive ciprofloxacin-treated patients was 34 +/- 33 days vs 45 +/- 71 days in the control group and this difference was not statistically significant. The duration of antibiotic therapy in the culture-positive ciprofloxacin-treated group was 27 +/- 15 days vs 33 +/- 50 days in the control group. Four of the 30 control patients required modification of their antibiotic regimen, whereas no ciprofloxacin-treated patient required a change. Ciprofloxacin appears to be an effective single agent in the treatment of ulcerative keratitis.
AuthorsD J Parks, D A Abrams, F A Sarfarazi, H R Katz
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 115 Issue 4 Pg. 471-7 (Apr 15 1993) ISSN: 0002-9394 [Print] United States
PMID8470719 (Publication Type: Case Reports, Comparative Study, Journal Article, Multicenter Study)
Chemical References
  • Gentamicins
  • Ciprofloxacin
  • Cefazolin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacterial Infections (drug therapy)
  • Cefazolin (administration & dosage)
  • Ciprofloxacin (therapeutic use)
  • Corneal Ulcer (drug therapy, microbiology)
  • Drug Therapy, Combination (therapeutic use)
  • Eye Infections, Bacterial (drug therapy)
  • Female
  • Gentamicins (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: